About 3 to 6% of all newborns require manual ventilation support to start breathing. Monivent has developed Neo100, a medical device providing continuous feedback on the volumes of air given to the baby during manual ventilation.
To secure a robust manufacturing process to enable market launch, Monivent has chosen to collaborate with Cenova AB. Together, the two companies have combined their different core competencies – Monivent, with extensive product knowledge, and Cenova, with more than 40 years of experience in securing a robust and clean production environment.
We all look forward to a long and successful collaboration for many years to come.